1030P Survival rates in high-risk neuroblastoma patients undergoing anti-GD2 immunotherapy: A single arm meta-analysis and systemic review.

Saved in:
Bibliographic Details
Title: 1030P Survival rates in high-risk neuroblastoma patients undergoing anti-GD2 immunotherapy: A single arm meta-analysis and systemic review.
Authors: Escalante Romero, L.1 (AUTHOR), Queiroz Costa Neto, I.2 (AUTHOR), Antunes, V.L.J.3 (AUTHOR), Matos Correia Rodrigues, M.1 (AUTHOR), Polo Mercado, J.R.4 (AUTHOR), Monteiro Caran, E.1 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS694-S695. 2p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first